fda warning bpc 157 safety human data "This is so scary for me because anytime you're injecting a medicine to the body that is not well studied in humans... that's incredibly frightening, especially since they're not approved.", "The FDA to discuss easing restrictions
Description
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

This closes the loop

Not intended to diagnose or treat disease and not a substitute for clinical consultation

What other peptides are related to BPC 157 and TB 500 research
They can reduce discomfort, provide support, and help with pouching issues, but they do not fix the underlying muscle defect
A: Safe when used as prescribed.
